Alys Pharmaceuticals
Boston, United States· Est.
An R&D anchored immuno-dermatology focused company to redefine the treatment landscape, bringing transformative solutions to patients worldwide.
Private Company
Total funding raised: $100M
About
An R&D anchored immuno-dermatology focused company to redefine the treatment landscape, bringing transformative solutions to patients worldwide.
AntibodiesBiologicsSmall Molecules
Funding History
1Total raised:$100M
Seed$100M